Medicare Enrolled
Dr. Radoslaw Kiesz, M.D.
Cardiovascular Disease · San Antonio, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kiesz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kiesz? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kiesz
Dr. Radoslaw Kiesz is a cardiovascular disease in San Antonio, TX, with 19 years in practice. Based on federal Medicare data, Dr. Kiesz performed 23,483 Medicare services across 2,832 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kiesz received a total of $19,969 from 41 pharmaceutical and/or device companies across 234 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are classified as financial or ownership interests (royalties, licensing fees, or investment interests). Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kiesz is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 0% volume in TX$ $19,969 industry payments
Medicare Practice Summary
Medicare Utilization ↗23,483
Medicare services
Top 0% in TX for cardiovascular disease
2,832
Unique beneficiaries
$21
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,236 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) | 9,531 | $0 | $2 |
| Injection, bivalirudin, 1 mg | 9,000 | $0 | $46 |
| Electrocardiogram (EKG), 12-lead | 1,156 | $10 | $54 |
| Office visit, established patient (30-39 min) | 1,041 | $92 | $200 |
| Regadenoson injection (Lexiscan) for heart stress test | 334 | $40 | $200 |
| Echocardiogram, transthoracic | 284 | $134 | $500 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 269 | $38 | $255 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 178 | $322 | $880 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 177 | $47 | $200 |
| Cardiac catheterization | 139 | $201 | $1,500 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 110 | $8 | $200 |
| Ultrasound of leg arteries at rest and after exercise | 96 | $103 | $350 |
| Ultrasonic guidance for blood vessel access | 95 | $14 | $156 |
| Coronary stent placement | 86 | $427 | $1,640 |
| Ultrasound of leg arteries or artery grafts | 75 | $176 | $435 |
| New patient office visit (45-59 min) | 75 | $121 | $300 |
| Ultrasound of both sides of head and neck blood flow | 74 | $133 | $250 |
| Blood test, basic group of blood chemicals (calcium, ionized) | 67 | $13 | $180 |
| Red blood cell concentration measurement | 67 | $2 | $48 |
| Blood count, hemoglobin | 67 | $2 | $48 |
| Injection, midazolam hydrochloride, per 1 mg | 67 | $0 | $10 |
| Injection, fentanyl citrate, 0.1 mg | 67 | $1 | $9 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 66 | $37 | $200 |
| Electrocardiogram (ecg) 2-day continuous | 64 | $14 | $54 |
| Review by radiologist of arm or leg artery image | 61 | $57 | $1,182 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 55 | $14 | $54 |
| Review by radiologist of both arms or legs arteries image | 47 | $62 | $1,143 |
| Review by radiologist of abdominal aorta image | 44 | $43 | $1,110 |
| Review by radiologist of additional artery image | 23 | $37 | $1,088 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 16 | $168 | $650 |
| Removal of plaque and insertion of stents in arteries of leg | 15 | $8,549 | $23,733 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 13 | $209 | $1,546 |
| New patient office visit (30-44 min) | 13 | $83 | $250 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial second order branch | 11 | $663 | $6,292 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.3% high complexity
83.5% medium
14.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$19,969
Total received (2018-2024)
Avg $2,853/year across 7 years
Top 19% in TX for cardiovascular disease
41
Companies
234
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$9,228 (46.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,470 (37.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,200 (16.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$71 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$857
2023$1,203
2022$1,439
2021$914
2020$515
2019$3,051
2018$11,990
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
BOSTON SCIENTIFIC CORPORATION
$8,049
Philips Electronics North America Corporation
$3,200
BIOTRONIK INC.
$1,443
Boston Scientific Corporation
$1,197
Abbott Laboratories
$917
Medtronic Vascular, Inc.
$617
Novartis Pharmaceuticals Corporation
$568
Esperion Therapeutics, Inc.
$564
Merck Sharp & Dohme LLC
$495
Medtronic, Inc.
$366
Amgen Inc.
$264
AngioDynamics, Inc.
$256
ABIOMED
$250
Penumbra, Inc.
$235
Cardinal Health 200, LLC
$231
iRhythm Technologies, Inc.
$139
Bayer Healthcare Pharmaceuticals Inc.
$125
LivaNova USA, Inc.
$125
Impulse Dynamics (USA) Inc.
$122
DeVoro Medical Inc.
$113
Acist Medical Systems, Inc.
$73
Allergan Inc.
$66
EKOS Corporation
$65
Venclose Inc.
$59
CARDIVA MEDICAL, INC.
$50
Amarin Pharma Inc.
$50
Cardiovascular Systems Inc.
$40
Regeneron Healthcare Solutions, Inc.
$38
Shockwave Medical, Inc
$34
Actelion Pharmaceuticals US, Inc.
$30
PFIZER INC.
$28
E.R. Squibb & Sons, L.L.C.
$24
SANOFI-AVENTIS U.S. LLC
$23
Novo Nordisk Inc
$21
Braemar Manufacturing, LLC
$21
W. L. Gore & Associates, Inc.
$19
Bard Peripheral Vascular, Inc.
$15
Merck Sharp & Dohme Corporation
$14
ARALEZ PHARMACEUTICALS US INC.
$12
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$6
Bardy Diagnostics, Inc.
$6
Top 3 companies account for 63.6% of total payments
Associated products mentioned in payments ›
AURYON LASER SYSTEM 100-120 VAC · Asahi Fielder coronary guide wire · Assurity Pacemaker · Azure · BYSTOLIC · CARDIVA VASCADE 6/7F VCS · COROFLOW · CVI Systems · Cardiac Monitoring Suite · Carnation Ambulatory Monitor · Confirm Rx · Corlanor · Crosser iQ · DIAMONDBACK PERIPHERAL · Diamondback Peripheral · EKOSONIC · ELIQUIS · ENTRESTO · EVKEEZA · EVRSF · EXPO · EluNIR Radaforolimus Eluting Coronary Stent System · Ensite Cardiac Mapping System · HAWKONE · HD-IVUS · HawkOne · IMPULSE · IVUS Systems · Impella · Indigo System · Kerendia · LEQVIO · LINZESS · LifeVest · MINI TREK · MYNX CONTROLTM · Micra · NANOCROSS ELITE · NC TREK coronary catheters · NEXLETOL · NEXLIZET · NHancer Rx · OPSUMIT MACITENTAN · OPTIMIZER · Optimizer · Orsiro Mission · PK Papyrus · PRALUENT · PRESSUREWIRE · Peripheral Orbital Atherectomy System · Pulsar-18 T3 · RUNWAY · Repatha · Resolute · Reveal LINQ · S.M.A.R.T. CONTROL Self-Expanding Nitinol Stent · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SelectSecure · Supera peripheral stent system · TURBOHAWK · TandemLife · VERQUVO · VIABAHN Endoprosthesis with Heparin Bioactive Surface · Vascepa · Vascular Closure Device · Vascular Lithotripsy · WATCHMAN FLX · WOLF · XIENCE SIERRA · XIENCE SKYPOINT · Xience Sierra Coronary Stent · Xience Sierra Coronary Stent System · ZIO XT Patch · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Payments are distributed across multiple categories with no single dominant type.
Equivalent to $85 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
150
Per 100K population
7.4
County median income
$70,571
Nearest hospital
SOUTH TEXAS SPINE AND SURGICAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Kiesz is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), and high industry engagement (mixed engagement, top 19%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Kiesz experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Kiesz performed 9,531 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kiesz receive payments from pharmaceutical companies?
Yes. Dr. Kiesz received a total of $19,969 from 41 companies across 234 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kiesz's costs compare to other cardiovascular diseases in San Antonio?
Dr. Kiesz's average Medicare payment per service is $21. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kiesz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in San Antonio
Browse cardiovascular diseases in San Antonio ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
BOSTON SCIENTIFIC CORPORATION Payments to Doctors
See all physicians who received payments from BOSTON SCIENTIFIC CORPORATION.
By company
Philips Electronics North America Corporation Payments to Doctors
See all physicians who received payments from Philips Electronics North America Corporation.
By company
BIOTRONIK INC. Payments to Doctors
See all physicians who received payments from BIOTRONIK INC..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology